UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more

follow us on twitter

Latest Announcements


UCL incubator at Stevenage Bioscience Catalyst reaches capacity with addition of two new projects

UCL’s bioscience incubator at the Stevenage Bioscience Catalyst (SBC) has now reached capacity following the migration of two further research projects to the facility from the university’s central London campus.


4 things a software startup learned during a week at Coca-Cola

The teams behind a pair of startups, Codacy and BaseStone (a UCL Start-up) , recently spent a week learning from Coca-Cola executives and Atlanta’s entrepreneurial community after taking top honors at the PITCH 2014 competition held during the Web Summit in Dublin, Ireland. The grand prize includes access to the Coca-Cola system’s relationships and resources. Here, Laura Davies from BaseStone shares what she and her colleagues learned during their time in Atlanta. More...

UCL Quad

New transitional appointments to the Senior Management Team

New transitional arrangements have been announced this week to cover the responsibilities of Professor Stephen Caddick, currently Vice-Provost (Enterprise), who will be stepping down from his role at the end of May to move to the Wellcome Trust as their Director of Innovations.


Finance charts

Finance and Value Creation Workshop

What would a businessman (or woman) think if you asked "What is NPV?", or if you didn't understand how an organisation creates value for its investors? More...

Technology Strategy

5-day CPD Accredited Technology Strategy Training for Small Businesses, Entrepreneurs, UCL Staff, Alumni and Post-graduate Students More...

Hand shake

How to Engage with Business

The 'How to engage with Businesses' workshop is one of a three part mini-course, Communicating Science to Business, which helps to prepare academics looking to maximise the benefits of presenting their academic research to business audiences.


London is a scientific powerhouse – and it’s about more than Nobel Prizes

By Stephen Caddick, Vice-Provost (Enterprise) at UCL
THE AWARD of the Nobel Prize in Physiology or Medicine this week to London-based professor John O’Keefe, along with his colleagues Moser and Moser, is well-deserved recognition for truly ground-breaking science – science which, in time, could have profound ramifications for the way we understand and treat neurological diseases like Alzheimer’s.

Market success for university research

The recent success of Imperial College in realising £10m cash in exchange for a 10 per cent share holding in Imperial Innovations shows the continued market interest in the commercialisation of university research (report, 24 June).

Letters to the Editor - 17/03 - Science startups, Best of Twitter

[Re: Why Britain’s scientists are failing at business, Friday]
Tim Farron is right to highlight some of the challenges facing all entrepreneurs in this country, but the idea that Britain’s scientific community is failing at business is simply not accurate. More...